Menzaghi Frederique Ph.D. 4
4 · Cara Therapeutics, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Menzaghi Frederique Ph.D.
VP-Research & Development
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+81,000→ 81,000 totalExercise: $10.06Exp: 2033-03-01→ Common Stock (81,000 underlying)
Footnotes (1)
- [F1]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2023, in each case subject to the Reporting Person's continued service as of each such date.